Antioxidative enzymes and increased oxidative stress in depressive women

Clinical Biochemistry

Volumn 42, Issue 13-14, 2009, Pages 1368-1374

  Kodydková, Jana ^a   Vávrová, Lucie ^a   Zeman, Miroslav ^a   Jirák, Roman ^a   Macášek, Jaroslav ^a   Staňková, Barbora ^a   Tvrzická, Eva ^a   Žák, Aleš ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Antioxidative enzymes; Conjugated dienes; Depressive disorder; Oxidative stress

Indexed keywords

ALKADIENE; ANTIOXIDANT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ARYLDIALKYLPHOSPHATASE 1; C REACTIVE PROTEIN; CALCIUM; CATALASE; CHOLESTEROL; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE REDUCTASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; ZINC;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL FEATURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OXIDATIVE STRESS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

AGED; ALKADIENES; ARYLDIALKYLPHOSPHATASE; CATALASE; DEPRESSIVE DISORDER; ENZYMES; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; SPECTROPHOTOMETRY; SUPEROXIDE DISMUTASE; TRIGLYCERIDES;

EID: 69249213963     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.06.006     Document Type: Article

References (60)

1. Kessler R.C., Berglund P., Demler O., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289 (2003) 3095-3105
2. Pirkola S.P., Isometsa E., Suvisaari J., et al. DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population-results from the Health 2000 Study. Soc. Psychiatry Psychiatr. Epidemiol. 40 (2005) 1-10
3. Czech Health Statistics Yearbook 2006 (2007), ÚZIS, Praha.
4. Hindmarch I. Beyond the monoamine hypothesis: mechanisms, molecules and methods. Eur. Psychiatry. 17 Suppl 3 (2002) 294-299
5. Malhi G.S., Parker G.B., and Greenwood J. Structural and functional models of depression: from sub-types to substrates. Acta. Psychiatr. Scand. 111 (2005) 94-105
6. Brown E.S., Varghese F.P., and McEwen B.S. Association of depression with medical illness: does cortisol play a role?. Biol. Psychiatry 55 (2004) 1-9
7. Kempermann G., and Kronenberg G. Depressed new neurons-adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression. Biol. Psychiatry 54 (2003) 499-503
8. Smith R.S. The macrophage theory of depression. Med. Hypotheses 35 (1991) 298-306
9. Evans P.H. Free radicals in brain metabolism and pathology. Br. Med. Bull. 49 (1993) 577-587
10. Sies H. Oxidative stress: oxidants and antioxidants. Exp. Physiol. 82 (1997) 291-295
11. Aslan M., and Ozben T. Reactive oxygen and nitrogen species in Alzheimer's disease. Curr. Alzheimer Res. 1 (2004) 111-119
12. Jenner P., and Olanow C.W. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47 (1996) 161-170
13. Mahadik S.P., and Mukherjee S. Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophr. Res. 19 (1996) 1-17
14. Licinio J., and Wong M.L. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol. Psychiatr. 4 (1999) 317-327
15. Moretti A., Gorini A., and Villa R.F. Affective disorders, antidepressant drugs and brain metabolism. Mol. Psychiatr. 8 (2003) 773-785
16. Mezuk B., Eaton W.W., Albrecht S., and Golden S.H. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 31 (2008) 2383-2390
17. Rugulies R. Depression as a predictor for coronary heart disease. A review and meta-analysis. Am. J. Prev. Med. 23 (2002) 51-61
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition (1994), Washington, D.C
19. Paglia D.E., and Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70 (1967) 158-169
20. Goldberg D.M., and SRJ. Assay of glutathione reductase. In: Bergmeyer H.U., Bergmeyer J., and Grassl M. (Eds). In Methods of Enzymatic Analysis (1983), Weinheim, Verlag Chemie 258-264
21. Aebi H. Catalase. In: Bergmeyer H.U. (Ed). Methods of Enzymatic Analysis (1974), Weinheim, Verlag Chemie 673-684
22. Štípek S., Crkovská J., and Dvořák V. Spectrophotometric assay for superoxide dismutase controlled by PC programme developed in LabWindows system. Klin. Biochem. Metab. 3 (1995) 93-97
23. Eckerson H.W., Wyte C.M., and La Du B.N. The human serum paraoxonase/arylesterase polymorphism. Am. J. Hum. Genet. 35 (1983) 1126-1138
24. Griffith O.W. Glutathione and glutathione disulphide. In: Bergemeyer H.U. (Ed). Methods of Enzymatic Analysis (1985), Weinheim, Verlag Chemie 521-529
25. Ahotupa M., Ruutu M., and Mantyla E. Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins. Clin. Biochem. 29 (1996) 139-144
26. Wieland H., and Seidel D. A simple specific method for precipitation of low density lipoproteins. J. Lipid Res. 24 (1983) 904-909
27. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
28. Smith M.A., Rottkamp C.A., Nunomura A., Raina A.K., and Perry G. Oxidative stress in Alzheimer's disease. Biochim. Biophys. Acta. 1502 (2000) 139-144
29. Koutsilieri E., ter M.V., and Riederer P. Neurotransmission in HIV associated dementia: a short review. J. Neural. Transm. 108 (2001) 767-775
30. Jenner P., and Olanow C.W. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47 (1996) 161-170
31. Maes M., De V.N., Pioli R., et al. Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. J. Affect Disord. 58 (2000) 241-246
32. Sarandol A., Sarandol E., Eker S.S., Erdinc S., Vatansever E., and Kirli S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum. Psychopharmacol. 22 (2007) 67-73
33. Bilici M., Efe H., Koroglu M.A., Uydu H.A., Bekaroglu M., and Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J. Affect. Disord. 64 (2001) 43-51
34. Herken H., Gurel A., Selek S., et al. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch. Med. Res. 38 (2007) 247-252
35. Ozcan M.E., Gulec M., Ozerol E., Polat R., and Akyol O. Antioxidant enzyme activities and oxidative stress in affective disorders. Int. Clin. Psychopharmacol. 19 (2004) 89-95
36. Andreazza A.C., Cassini C., Rosa A.R., et al. Serum S100B and antioxidant enzymes in bipolar patients. J. Psychiatr. Res. 41 (2007) 523-529
37. Geier D.A., Kern J.K., Garver C.R., et al. Biomarkers of environmental toxicity and susceptibility in autism. J. Neurol. Sci. 280 (2009) 101-108
38. Vojdani A., Mumper E., Granpeesheh D., et al. Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15. J. Neuroimmunol. 205 (2008) 148-154
39. Altuntas I., Aksoy H., Coskun I., Cayköylü A., and Akçay F. Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients. Clin. Chem. Lab. Med. 38 (2000) 1277-1281
40. Muchova J., Garaiova I., and Sustrova M. The redox state of glutathione in erythrocytes of individuals with Down syndrome. Bratisl. Lek. Listy. 108 (2007) 70-74
41. Griendling K.K., Sorescu D., and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Cirk. Res. 86 (2000) 494-501
42. Kojda G., and Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc. Res. 43 (1999) 562-571
43. Harrison R. Physiological roles of xanthine oxidoreductase. Drug Metab. Rev. 36 (2004) 363-375
44. + channel function impairment after brain injury. Brain Res. 910 (2001) 19-28
45. Babior B.M. NADPH oxidase: an update. Blood 93 (1999) 1464-1476
46. Khanzode S.D., Dakhale G.N., Khanzode S.S., Saoji A., and Palasodkar R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox. Rep. 8 (2003) 365-370
47. Forman H.J., and Fridovich I. On the stability of bovine superoxide dismutase. The effects of metals. J. Biol. Chem. 248 (1973) 2645-2649
48. Szuster-Ciesielska A., Slotwinska M., Stachura A., et al. Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression. Prog.Neuropsychopharmacol. Biol. Psychiatry 32 (2008) 686-694
49. Amstad P., Peskin A., Shah G., et al. The balance between Cu,Zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochemistry 30 (1991) 9305-9313
50. Halliwell B., and Gutteridge J.M.C. Free Radical in Biology and Medicine. 4th ed. (2007), Oxford University Press, New York 123
51. Rabini R.A., Tesei M., Galeazzi T., Dousset N., Ferretti G., and Mazzanti L. Increased susceptibility to peroxidation of VLDL from non-insulin-dependent diabetic patients: a possible correlation with fatty acid composition. Mol. Cell. Biochem. 199 (1999) 63-67
52. Zak A., Tvrzicka E., Vecka M., et al. Severity of metabolic syndrome unfavorably influences oxidative stress and fatty acid metabolism in men. Tohoku. J. Exp. Med. 212 (2007) 359-371
53. Zeman M., Zak A., Vecka M., Tvrzicka E., Pisarikova A., and Stankova B. N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination. J. Nutr. Biochem. 17 (2006) 379-384
54. Gavella M., Lipovac V., Car A., and Vucic M. Baseline diene conjugation in LDL lipids from newly diagnosed type 2 diabetic patients. Diabetes Metab. 28 (2002) 391-396
55. Furukawa S., Fujita T., Shimabukuro M., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114 (2004) 1752-1761
56. Kazdová L., Zák A., and Vrána A. Increased lipoprotein oxidability and aortic lipid peroxidation in an experimental model of insulin resistance syndrome. Ann. N.Y. Acad. Sci. 827 (1997) 521-525
57. Zeman M., Zak A., Vecka M., Tvrzicka E., Romaniv S., and Konarkova M. Treatment of hypertriglyceridemia with fenofibrate, fatty acid composition of plasma and LDL, and their relations to parameters of lipoperoxidation of LDL. Ann. N.Y. Acad. Sci. 967 (2002) 336-341
58. Kesavulu M.M., Giri R., Kameswara Rao B., and Apparao C. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab. 26 (2000) 387-392
59. Ramakrishna V., and Jailkhani R. Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients. Acta. Diabetol. 45 (2008) 41-46
60. Espinola-Klein C., Rupprecht H.J., Bickel C., et al. Glutathione peroxidase-1 activity, atherosclerotic burden, and cardiovascular prognosis. Am. J. Cardiol. 99 (2007) 808-812